La Nanomedicina
Download
1 / 21

- PowerPoint PPT Presentation


  • 108 Views
  • Uploaded on

La Nanomedicina Prof. Dr. Josep Samitier Univ. De Barcelona Lab Nanobioingeniería (IBEC) Coordinador Plataforma Española de Nanomedicina Director Adjunto CIBER BBN. Informe FENIN 2006 Biotecnologia. Nuevas Tecnologías. Miniaturización. Técnicas clásicas (Macro) Microdispositivos

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about '' - jacques


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg

La Nanomedicina

Prof. Dr. Josep Samitier

Univ. De Barcelona

Lab Nanobioingeniería (IBEC)

Coordinador Plataforma Española de Nanomedicina

Director Adjunto CIBER BBN



Slide3 l.jpg

Nuevas Tecnologías

Miniaturización

Técnicas clásicas (Macro)

Microdispositivos

Nanotecnología

Convergencia de tecnologías

Richard Feynman



Slide6 l.jpg

Definition: NanoMedicine, for the purpose of this vision document, is defined as the application of Nanotechnology to Health. It exploits the improved and often novel physical, chemical, and biological properties of materials at

the nanometric scale. NanoMedicine has potential impact on the prevention, early and reliable diagnosis and treatment of diseases.


Entorn internacional l.jpg

NIH Nanomedicine Roadmap Initiative, emprendida por el Instituto Nacional de Salud de EE.UU en mayo de 2004 (http://www.capconcorp.com/roadmap04/)

ESF Scientific Forward Look on Nanomedicine, presentado por el comité de expertos de la European Science Foundation en febrero de 2005 (http://www.esf.org/newsrelease/83/SPB23Nanomedicine.pdf)

EuroNanoForum 2005, Nanotechnology and the Health of the EU Citizen in 2020 (Edimburgo, 6 – 9 septiembre de 2005).

Entorn internacional



Slide9 l.jpg

PRESENTACIÓN

DEL INFORME

PLATAFORMA

ESPAÑOLA

DE NANOMEDICINA


Slide10 l.jpg

PLATAFORMA ESPAÑOLA DE NANOMEDICINA

Jornadas de Plataformas Tecnológicas

Josep Samitier

Parc Científic de Barcelona-Univ. de Barcelona

Institut de Bioenginyeria de Catalunya (IBEC)


Slide11 l.jpg

MIEMBROS

108 grupos diferentes


Slide12 l.jpg

GRUPOS DE TRABAJO

  • Nanodiagnóstico

  • Medicina Regenerativa

  • Liberación de Fármacos

  • Educación / Comunicación

  • Toxicidad / Regulación


Slide13 l.jpg

MIEMBROS

Por Comunidades Autónomas


Slide14 l.jpg

EURONANOBIO WP1 Experts Workshop

Nanobio Clusters: identifying best practices

Dr Arantxa Sanz

Prof. Josep Samitier

Institute for Bioengineering of Catalonia (IBEC)

Barcelona, SPAIN


Wp1 objectives and method l.jpg
WP1:OBJECTIVES AND METHOD

GLOBAL OBJECTIVE:

Identifying best practices across the most successful clusters

As integration is key to success in nanobio, success = high quality, common research projects and results (with diverse cluster members as partners)

DATA COLLECTION and ANALYSIS: METHODOLOGY (Feb-May 09)

  • Definition of a nanobio cluster in the study: research vs innovation cluster

  • Mapping clusters elsewhere: USA, Canada, Asia-Pacific

  • Mapping clusters in Europe

  • Identifying best practices via SWOT analysis

  • Consolidation workshop: discussion and brainstorming


Usa mapping preliminary results l.jpg

Clinical

Research

Innovation

Cluster agency

Cluster agency non specific

USA: mapping preliminary results

BAY AREA

SOUTH CALIFORNIA

HOUSTON

CHICAGO

BOSTON

CORNELL

N. CAROLINA


Asia pacific preliminary results l.jpg

Clinical

Research

Innovation

Cluster agency

Cluster agency non specific

ASIA PACIFIC – preliminary results

TSUKUBA / TOKYO

KOBE

YONSEI (SEOUL)

SINGAPORE

SIDNEY …


European union mapping preliminary results l.jpg

Clinical

Research

Innovation

Cluster agency

Cluster agency non specific

European Union: mapping preliminary results

Most advanced nanobio clusters across EU + associate states:

-Higher integration level of actors, including hospitals

-Remarkable common output in terms of funded projects, research papers and patents / creation of spin off companies